Sex bias in pain management decisions.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
13 Aug 2024
Historique:
medline: 5 8 2024
pubmed: 5 8 2024
entrez: 5 8 2024
Statut: ppublish

Résumé

In the pursuit of mental and physical health, effective pain management stands as a cornerstone. Here, we examine a potential sex bias in pain management. Leveraging insights from psychological research showing that females' pain is stereotypically judged as less intense than males' pain, we hypothesize that there may be tangible differences in pain management decisions based on patients' sex. Our investigation spans emergency department (ED) datasets from two countries, including discharge notes of patients arriving with pain complaints (N = 21,851). Across these datasets, a consistent sex disparity emerges. Female patients are less likely to be prescribed pain-relief medications compared to males, and this disparity persists even after adjusting for patients' reported pain scores and numerous patient, physician, and ED variables. This disparity extends across medical practitioners, with both male and female physicians prescribing less pain-relief medications to females than to males. Additional analyses reveal that female patients' pain scores are 10% less likely to be recorded by nurses, and female patients spend an additional 30 min in the ED compared to male patients. A controlled experiment employing clinical vignettes reinforces our hypothesis, showing that nurses (N = 109) judge pain of female patients to be less intense than that of males. We argue that the findings reflect an undertreatment of female patients' pain. We discuss the troubling societal and medical implications of females' pain being overlooked and call for policy interventions to ensure equal pain treatment.

Identifiants

pubmed: 39102546
doi: 10.1073/pnas.2401331121
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2401331121

Subventions

Organisme : Israel Science Foundation (ISF)
ID : 2824/22
Organisme : Israel Science Foundation (ISF)
ID : 354/21
Organisme : HHS | NIH | National Institute on Aging (NIA)
ID : AG061824

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Mika Guzikevits (M)

Hebrew University Business School, Hebrew University of Jerusalem, Jerusalem 9190501, Israel.
Federmann Center for the Study of Rationality, Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Tom Gordon-Hecker (T)

Department of Business Administration, Ben-Gurion University of the Negev, Be'er-Sheva 8410501, Israel.

David Rekhtman (D)

The Department of Emergency Medicine, Hadassah Medical Center, Jerusalem 9112001, Israel.

Shaden Salameh (S)

The Department of Emergency Medicine, Hadassah Medical Center, Jerusalem 9112001, Israel.

Salomon Israel (S)

Psychology department, Hebrew University of Jerusalem, Jerusalem 9190501, Israel.

Moses Shayo (M)

Federmann Center for the Study of Rationality, Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Economics department, Hebrew University of Jerusalem, Jerusalem 9190501, Israel.

David Gozal (D)

The University of Missouri School of Medicine, Columbia, MO 65201.
Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701.

Anat Perry (A)

Psychology department, Hebrew University of Jerusalem, Jerusalem 9190501, Israel.

Alex Gileles-Hillel (A)

Pediatric Pulmonology Unit, Department of Pediatrics, Hadassah Medical Center, Jerusalem 9112001, Israel.
The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.

Shoham Choshen-Hillel (S)

Hebrew University Business School, Hebrew University of Jerusalem, Jerusalem 9190501, Israel.
Federmann Center for the Study of Rationality, Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH